Current status of therapy for breast cancer worldwide and in Japan - Wikidata - awgldk - TriplyDB

Current status of therapy for breast cancer worldwide and in Japan

Current status of therapy for breast cancer worldwide and in Japan

http://www.wikidata.org/entity/Q34983835

about

Management and outcomes of male breast cancer in zaria, Nigeria.RETRACTED: Management of postoperative nausea and vomiting in women scheduled for breast cancer surgery.

P2860

Q36237606-1F6BAEC1-4CC6-4CAC-AD29-D948C46B197C Q37941476-672B9FC8-1E3D-4C60-9612-196702B23511

P2860

Current status of therapy for breast cancer worldwide and in Japan

http://www.wikidata.org/entity/Q34983835

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Current status of therapy for breast cancer worldwide and in Japan

@ast

Current status of therapy for breast cancer worldwide and in Japan

@en

Current status of therapy for breast cancer worldwide and in Japan

@nl

type

label

Current status of therapy for breast cancer worldwide and in Japan

@ast

Current status of therapy for breast cancer worldwide and in Japan

@en

Current status of therapy for breast cancer worldwide and in Japan

@nl

prefLabel

Current status of therapy for breast cancer worldwide and in Japan

@ast

Current status of therapy for breast cancer worldwide and in Japan

@en

Current status of therapy for breast cancer worldwide and in Japan

@nl

P1433

Q34983835-3325A04A-A2E2-4998-A976-06FBD5C5D388

P1476

Q34983835-78EE53CB-403F-46C4-B3EF-94E97BE67822

P2093

Q34983835-3A5CCD01-114C-4442-959A-6EDEE8CF1CFD

Q34983835-B0C5AF8B-87CC-4164-8B89-A310FD956158

Q34983835-B9BF0970-0118-4D16-A248-455742A04D64

Q34983835-E023B740-9220-474B-B94D-2B832948BEC2

P2860

Q34983835-09B91EBC-ABB3-4231-BE2E-B03B8B1BD782

Q34983835-1E36C6FE-BEFA-45C8-86C2-4F63EE4217FA

Q34983835-44CB80F3-748B-4748-9232-D1E46D73137C

Q34983835-4D5B700C-476A-4964-95D3-47DD8CD774CA

Q34983835-64510F65-7120-48BB-8A89-87F140B13D74

Q34983835-675A37BB-7E7F-4E59-8B52-42EC846D1689

Q34983835-68A99E82-606B-4721-8BAC-0E579B0639A2

Q34983835-872F32AF-CEE5-49E2-8850-258794CE4BD0

Q34983835-BC90EB8D-0C6E-4537-B576-9AA93B530C82

Q34983835-C15F63FC-FA81-4731-A829-FFE2EF25D455

P304

Q34983835-89E42B32-07C0-4671-AB69-B62EEBEA592B

P31

Q34983835-06D34F69-C46C-4220-8136-23F2C4762C44

P356

Q34983835-522899E4-6290-491A-844E-BC69EF7AB6E4

P433

Q34983835-EA2369E2-3E58-4D78-9939-37E694106292

P478

Q34983835-3616BD4E-F185-475B-A10D-D15966157E9D

P577

Q34983835-54A7746B-8F47-448F-8837-91D995ED7D42

P5875

Q34983835-28980186-DBE5-47F2-A058-81592FCAF0A3

P698

Q34983835-FB5EBCCC-1862-4CAF-AB6E-22EAD9E432A6

P932

Q34983835-317E456C-AFBE-4B96-A0B5-57C7A070FCF8

P356

P1433

World journal of clinical oncology

P1476

Current status of therapy for breast cancer worldwide and in Japan

@en

P2093

Ryoji Kato

http://www.w3.org/2001/XMLSchema#string

Ryuichi Takagi

http://www.w3.org/2001/XMLSchema#string

Tomoaki Kitahara

http://www.w3.org/2001/XMLSchema#string

Youngjin Park

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.

Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N.SAS-BC 01 trial and CUBC t

Results of questionnaire survey on breast cancer surgery in Japan 2004-2006.

Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.

P304

125-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V2.I2.125

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51156902

http://www.w3.org/2001/XMLSchema#string

P698

21603322

http://www.w3.org/2001/XMLSchema#string

P932

3095468

http://www.w3.org/2001/XMLSchema#string